Thomas Weber

10PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 16, 2025
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma.

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib

|Jul 14, 2023
Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells.

Sebastian W Schleser, Oleksandr Krytovych, Tim Ziegelmeier

|Jun 10, 2023
SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters.

Elisabeth Groß, Ralf-Axel Hilger, Franziska Lea Schümann

|Jan 25, 2023
Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms.

Amelie Jaeger, Sudheer Madan Mohan Gambheer, Xiaoyang Sun

|Dec 24, 2021
Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas.

Franziska Lea Schümann, Elisabeth Groß, Marcus Bauer

|Oct 13, 2021
RBMX Protein Expression in T-Cell Lymphomas Predicts Chemotherapy Response and Prognosis.

Franziska Lea Schümann, Marcus Bauer, Elisabeth Groß

Pageof 2

Frequent Collaborators

5 joint publications

Elisabeth Groß

3 joint publications

Marcus Bauer

2 joint publications

Christian R Schultze-Florey

2 joint publications

Enver Aydilek